HCA Holdings, Inc. (NYSE:HCA) – Equities researchers at Leerink Swann dropped their Q2 2017 earnings per share estimates for HCA Holdings in a report released on Wednesday. Leerink Swann analyst A. Gupte now forecasts that the company will post earnings per share of $1.79 for the quarter, down from their prior estimate of $1.83. Leerink Swann has a “Outperform” rating and a $100.00 price target on the stock. Leerink Swann also issued estimates for HCA Holdings’ Q4 2017 earnings at $2.08 EPS and FY2017 earnings at $7.34 EPS.
HCA Holdings (NYSE:HCA) last announced its quarterly earnings data on Tuesday, May 2nd. The company reported $1.74 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $1.74. HCA Holdings had a negative return on equity of 45.28% and a net margin of 6.70%. The company had revenue of $10.62 billion for the quarter, compared to analyst estimates of $10.64 billion. During the same quarter in the previous year, the company earned $1.71 EPS. The firm’s revenue for the quarter was up 3.5% compared to the same quarter last year. WARNING: This piece was posted by BBNS and is the property of of BBNS. If you are viewing this piece on another site, it was copied illegally and republished in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://baseballnewssource.com/markets/research-analysts-offer-predictions-for-hca-holdings-inc-s-q2-2017-earnings-hca-updated-updated-updated/1194621.html.
Several other equities analysts also recently commented on the stock. Mizuho upgraded shares of HCA Holdings from a “neutral” rating to a “buy” rating and set a $98.00 price objective on the stock in a research note on Monday, March 27th. Cantor Fitzgerald reiterated a “buy” rating and set a $95.00 price objective on shares of HCA Holdings in a research note on Monday, April 17th. Zacks Investment Research downgraded shares of HCA Holdings from a “buy” rating to a “hold” rating in a research note on Tuesday, March 28th. Deutsche Bank AG assumed coverage on shares of HCA Holdings in a research note on Tuesday, April 4th. They set a “buy” rating and a $103.00 price objective on the stock. Finally, Morgan Stanley assumed coverage on shares of HCA Holdings in a research note on Tuesday, June 6th. They set an “equal weight” rating and a $90.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and thirteen have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $92.71.
HCA Holdings (NYSE:HCA) opened at 86.57 on Friday. HCA Holdings has a 12 month low of $67.00 and a 12 month high of $91.03. The firm has a market capitalization of $31.76 billion, a P/E ratio of 11.76 and a beta of 0.69. The company’s 50 day moving average price is $83.81 and its 200 day moving average price is $82.95.
A number of hedge funds have recently bought and sold shares of the stock. BlackRock Inc. increased its stake in HCA Holdings by 2,549.4% in the first quarter. BlackRock Inc. now owns 20,099,811 shares of the company’s stock valued at $1,788,682,000 after buying an additional 19,341,168 shares during the last quarter. FMR LLC increased its stake in HCA Holdings by 15.8% in the first quarter. FMR LLC now owns 7,763,884 shares of the company’s stock valued at $690,908,000 after buying an additional 1,059,925 shares during the last quarter. Old Mutual Global Investors UK Ltd. increased its stake in HCA Holdings by 44.6% in the first quarter. Old Mutual Global Investors UK Ltd. now owns 1,627,311 shares of the company’s stock valued at $144,814,000 after buying an additional 501,591 shares during the last quarter. Morgan Stanley increased its stake in HCA Holdings by 51.7% in the first quarter. Morgan Stanley now owns 1,186,998 shares of the company’s stock valued at $105,630,000 after buying an additional 404,599 shares during the last quarter. Finally, Vanguard Group Inc. increased its stake in HCA Holdings by 1.9% in the first quarter. Vanguard Group Inc. now owns 19,576,992 shares of the company’s stock valued at $1,742,157,000 after buying an additional 361,027 shares during the last quarter. 74.51% of the stock is owned by institutional investors and hedge funds.
In other news, insider Jonathan B. Perlin sold 71,063 shares of HCA Holdings stock in a transaction on Thursday, June 22nd. The shares were sold at an average price of $86.00, for a total value of $6,111,418.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Michael S. Cuffe sold 2,150 shares of HCA Holdings stock in a transaction on Monday, April 17th. The shares were sold at an average price of $85.00, for a total transaction of $182,750.00. Following the completion of the sale, the insider now owns 12,254 shares of the company’s stock, valued at approximately $1,041,590. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 397,424 shares of company stock valued at $33,231,714. Company insiders own 2.90% of the company’s stock.
HCA Holdings Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with our FREE daily email newsletter.